The China facility recently cleared the USFDA audit, positioning Cipla to initiate US supplies by the second half of FY 2024-25
Read MoreAccording to an exchange filing, the demand covers assessment years from 2015-16 to 2022-23, following assessment and re-assessment orders issued on 12 July
Read More